- Home
- MI vs LGVN Comparison
MI vs LGVN Comparison
Compare MI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MI
- LGVN
- Stock Information
- Founded
- MI 2009
- LGVN 2014
- Country
- MI Hong Kong
- LGVN United States
- Employees
- MI N/A
- LGVN N/A
- Industry
- MI Catalog/Specialty Distribution
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- MI Consumer Discretionary
- LGVN Health Care
- Exchange
- MI Nasdaq
- LGVN Nasdaq
- Market Cap
- MI 17.8M
- LGVN 16.4M
- IPO Year
- MI N/A
- LGVN 2021
- Fundamental
- Price
- MI N/A
- LGVN $0.89
- Analyst Decision
- MI
- LGVN Strong Buy
- Analyst Count
- MI 0
- LGVN 2
- Target Price
- MI N/A
- LGVN $6.50
- AVG Volume (30 Days)
- MI 15.5K
- LGVN 399.0K
- Earning Date
- MI 01-01-0001
- LGVN 11-11-2025
- Dividend Yield
- MI N/A
- LGVN N/A
- EPS Growth
- MI N/A
- LGVN N/A
- EPS
- MI N/A
- LGVN N/A
- Revenue
- MI $662,718.00
- LGVN $2,073,000.00
- Revenue This Year
- MI N/A
- LGVN N/A
- Revenue Next Year
- MI N/A
- LGVN N/A
- P/E Ratio
- MI N/A
- LGVN N/A
- Revenue Growth
- MI N/A
- LGVN 68.67
- 52 Week Low
- MI $1.57
- LGVN $0.63
- 52 Week High
- MI $10.29
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- MI N/A
- LGVN 48.25
- Support Level
- MI N/A
- LGVN $0.73
- Resistance Level
- MI N/A
- LGVN $0.82
- Average True Range (ATR)
- MI 0.00
- LGVN 0.03
- MACD
- MI 0.00
- LGVN 0.02
- Stochastic Oscillator
- MI 0.00
- LGVN 94.35
About MI NFT Limited
NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.